MMPSI（Cat No.:I011534）is a small molecule inhibitor designed to target and inhibit matrix metalloproteinases (MMPs), a family of enzymes involved in the breakdown of extracellular matrix components. MMPs play a crucial role in processes such as tissue remodeling, wound healing, and cancer metastasis. By inhibiting MMPs, MMPSI aims to prevent the degradation of the extracellular matrix, thereby reducing tumor invasion, angiogenesis, and inflammation. It is being explored in preclinical research for its therapeutic potential in treating cancer, fibrosis, and other diseases characterized by excessive MMP activity and tissue damage.